Free Trial

LY 8/3/2023 Earnings Report

$2.98 0.00 (0.00%)
As of 04/10/2025

PharmChem EPS Results

Actual EPS
$0.07
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

PharmChem Revenue Results

Actual Revenue
$3.14 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

PharmChem Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

PharmChem's next earnings date is estimated for Monday, April 28, 2025, based on past reporting schedules.

Conference Call Resources

Remove Ads

PharmChem Earnings Headlines

PharmChem considers strategic alternatives
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
Cedar Creek Partners Q3 2024 Results
See More PharmChem Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PharmChem? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PharmChem and other key companies, straight to your email.

About PharmChem

PharmChem (OTCMKTS:PCHM) provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.

View PharmChem Profile

More Earnings Resources from MarketBeat